Lirametostat (CPI-1205) CAS:1621862-70-1
Lirametostat (CPI-1205)
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-C-1556 | 5mg | 125.00 | + Add to cart |
|
R-C-1556 | 10mg | 225.00 | + Add to cart |
|
R-C-1556 | 50mg | 980.00 | + Add to cart |
|
|
Product description
Lirametostat (CPI-1205) is an orally available selective inhibitor of the histone lysine methyltransferase EZH2 with IC50 values of 2 nM and 52 nM for EZH2 and EZH1 respectively. It has potential antineoplastic activity.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
purity | >95% |
PDI by GPC | <1.5 |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product